Skip to main content
. 2021 Sep 22;22:813. doi: 10.1186/s12891-021-04673-z

Table 2.

Patient demographics and comorbidities

Overall RG TG P
Patients N 58 31 27
Sex f / m 41 / 17 26 / 5 15 / 12
Age (years) Mean (min – max) 69,9 ± 14,9 (22–93) 76,2 ± 9,4* (49–93) 62,9 ± 16,7* (22–93) *p < 0.05
BMI (kg/m2) Mean ± SD (min – max) 26,7 ± 4,3 (20.9–39.1) 27,3 ± 4,3 (21,3 - 39,1) 24,9 ± 3,9 (20,9 - 36,5) p = n.s. (0.097)
Affected side right / left 30 / 28 18 / 13 12 / 15
Follow-up (months) Mean (min – max) 52.2 (11–160) 49,0 (11–139) 55,9 (14–160)
Comorbidities
 - Patients N (%) 36 (62.1%) 25 (80.6%)* 11 (40.7%)* *p < 0.001
 - Hypertension 22 15 7
 - Diabetes 7 4 3
 - COPD 3 2 1
 - Congestive heart failure 4 3 1
 - CAD 2 2
 - Cardiac arrhythmia 8 4 4
 - Hypothyroidism 5 3 2
 - Chronic renal failure 3 3
 - Neoplasia 4 2 2
 - Decubitus 1 1
 - Arthrosis 2 2
 - Dementia 2 2
 - Depression 1 1
 - Schizophrenia 1 1
 - Cerebrovascular insult 1 1
 - Epilepsia 1 1

RG Revision group, TG Tumor group, f Female, m Male, BMI Body-mass-index, COPD Chronic obstructive pulmonary disease, CAD Coronary artery disease